| Trial ID: | L7110 |
| Source ID: | NCT01473147
|
| Associated Drug: |
Exenatide
|
| Title: |
Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
|
| Acronym: |
AGAC2
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Exenatide|DRUG: Normal saline
|
| Outcome Measures: |
Primary: Mean amplitude of glycaemic excursions (MAGE), During 6-day treatment course | Secondary: homeostasis model assessment(HOMA), During 6-day treatment course
|
| Sponsor/Collaborators: |
Sponsor: Chang Gung Memorial Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
51
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-10
|
| Completion Date: |
2013-06
|
| Results First Posted: |
|
| Last Update Posted: |
2013-07-30
|
| Locations: |
Chang Gung Memorial Hospital, Taoyuan, 333, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT01473147
|
